webinar register page

Webinar banner
Navigating the Risks of Prescribing Opioids for Chronic Pain in the COVID-19 Era


Jul 22, 2020 11:30 AM

Webinar logo
* Required information


Jesse Caplan
Managing Director of Corporate Oversight @Affiliated Monitors, Inc.
Jesse Caplan is an attorney and Managing Director of Corporate Oversight for Affiliated Monitors. Jesse has served as the General Counsel of the Massachusetts Executive Office of Health and Human Services, as a partner with Epstein, Becker and Green, a national health care law firm, and as Chief Legal Counsel for an HMO. At Affiliated Monitors, he oversees assessment and monitoring of healthcare organizations, including hospital systems, addiction treatment facilities, and health insurers.
Debbie Waugh
Director, Assessment Services @Affiliated Monitors, Inc.
Deb Waugh is a Licensed Clinical Social Worker and is the Director of Assessment Services for Affiliated Monitors. Deb has years of experience designing and implementing physician competency evaluations and training programs, including as the former Program Director for the Center for Personalized Education for Physicians (CPEP), and founder of Clinical Competence Solutions, an educational resource for healthcare practitioners. At Affiliated Monitors, Deb oversees the assessment and monitoring of physicians on behalf of licensing boards and agencies in over 40 states.
Amy Fogelman, M.D.
CEO & Medical Director @Med Law Consulting, LLC
Amy Fogelman, M.D. is Board Certified in Internal Medicine, is a practicing physician and is the founder of MED LAW Consulting. Amy is an expert in opioid prescribing practices. Among other achievements, Amy led a multi-disciplinary group of addiction experts and hospital leaders to create a first-of-its-kind hospital-wide Primary Care pain policy at Massachusetts General Hospital in Boston. Amy was also appointed to serve as a member of the Special Commission to Study Medication-Assisted Treatment for Opioid Use Disorder in Massachusetts. Amy has been an instructor at Harvard Medical School, and has assessed the opioid prescribing practices of scores of physicians and physician extenders, identifying gaps in their standard of care and recommending strategies for improvement.